The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.

Frequency of Eye Diseases in Subjects Aged 40 and Over. Open Journal of Ophthalmology, 15, 11-17. doi: ...

I'm A Celebrity fans have sparked a major debate over which of the final three stars deserves to win. Read more.

TOKYO -- Japanese researchers from Keio University and elsewhere announced Thursday that they have begun a clinical trial on a gene therapy to restore light sensitivity in patients with retinitis ...

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...

The comedian, who became the first blind person to win Strictly Come Dancing in 2024, opened up about the 'shame' he felt ...

The DVLA must be notified of any condition that affects both eyes or the single eye if you only have vision in one. Failing ...